Moelis & Co. Shares Soar 0.76% to 2025 High

Moelis A(MC) shares rose to their highest level since March 2025 today, with an intraday gain of 0.76%.

The strategy of buying MC shares after they reached a recent high and holding for 1 week yielded mixed results over the past 5 years. While there were some profitable periods, such as the 12-month gain of 14.2% starting from the high point, there were also significant losses, like the -12.6% loss in the first week following the high. The overall performance was underwhelming, with an average weekly return of -0.7% and a total return of -2.9% over the 5-year period. This suggests that this strategy often failed to capitalize on the post-high momentum, leading to underperformance. The longest continuous gain was 14.2% over 12 months, indicating that holding MC shares for a longer period could be more beneficial than the weekly holding strategy. However, the strategy also had periods of significant underperformance, highlighting the risks associated with relying solely on post-high momentum for investment decisions.

Moelis & Co's stock has seen a significant boost recently, driven by several key developments. On June 23, 2025, Morgan Stanley upgraded Moelis from "Underweight" to "Overweight," raising the price target from $42 to $68. This upgrade reflects a positive outlook due to Moelis' promising deal pipeline and a recovering market. Additionally, Moelis' first-quarter 2025 earnings report revealed a 41% increase in revenue year-over-year, reaching $307 million, which underscores the company's strong financial performance. These factors, along with strategic investments in its private funds advisory business, have strengthened Moelis' market position, suggesting continued growth and investor interest.